Novavax Stock Income Statements

Novavax Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

Novavax Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31

revenue:
product sales	10,724,000	621,678,000	49,774,000	38,210,000	19,904,000	82,324,000	251,452,000	2,231,000	285,163,000	-7,457,000	287,787,000	626,091,000	55,455,000	585,628,000																																																											1,627,000	3,647,000	1,959,000					4,776,000
licensing, royalties, and other	228,516,000	44,977,000	38,537,000	46,302,000	395,580,000
total revenue	239,240,000	666,655,000	88,311,000	84,512,000	415,484,000	93,855,000	291,342,000	186,986,000	424,426,000	80,951,000	357,399,000	734,577,000	185,925,000	703,971,000	222,200,000	178,844,000	298,017,000	447,229,000	2,507,000	35,538,000	3,377,000	8,816,000	2,507,000	3,357,000	3,982,000	6,127,000	7,735,000	10,773,000	9,653,000	10,412,000	8,352,000	6,732,000	5,680,000	5,399,000	3,231,000	2,505,000	4,218,000	5,853,000	6,525,000	13,996,000	9,877,000	8,214,000	8,259,000	7,462,000
yoy	-42.42%	610.30%	-69.69%	-54.80%	-2.11%	15.94%	-18.48%	-74.55%	128.28%	-88.50%	60.85%	310.74%	-37.61%	57.41%	8763.18%	403.25%	8724.90%	4972.92%	0.00%	958.62%	-15.19%	43.89%	-67.59%	-68.84%	-58.75%	-41.15%	-7.39%	60.03%	69.95%	92.85%	158.50%	168.74%	34.66%	-7.76%	-50.48%	-82.10%	-57.29%	-28.74%	-21.00%	87.56%
qoq	-64.11%	654.89%	4.50%	-79.66%	342.69%	-67.79%	55.81%	-55.94%	424.30%	-77.35%	-51.35%	295.09%	-73.59%	216.82%	24.24%	-39.99%	-33.36%	17739.21%	-92.95%	952.35%	-61.69%	251.66%	-25.32%	-15.70%	-35.01%	-20.79%	-28.20%	11.60%	-7.29%	24.66%	24.06%	18.52%	5.20%	67.10%	28.98%	-40.61%	-27.93%	-10.30%	-53.38%	41.70%	20.25%	-0.54%	10.68%
expenses:
cost of sales	15,325,000	14,115,000	36,669,000	60,619,000	46,242,000	59,209,000	154,976,000	98,929,000	55,777,000	34,086,000	181,765,000	434,593,000	271,077,000	15,204,000																																																											346,000	761,000	388,000
gross profit	223,915,000	652,540,000	51,642,000	23,893,000	369,242,000	34,646,000	136,366,000	88,057,000	368,649,000	46,865,000	175,634,000	299,984,000	-85,152,000	688,767,000
yoy	-39.36%	1783.45%	-62.13%	-72.87%	0.16%	-26.07%	-22.36%	-70.65%	-532.93%	-93.20%
qoq	-65.69%	1163.58%	116.14%	-93.53%	965.76%	-74.59%	54.86%	-76.11%	686.62%	-73.32%	-41.45%	-452.29%	-112.36%
gross margin %	93.59%	97.88%	58.48%	28.27%	88.87%	36.91%	46.81%	47.09%	86.86%	57.89%	49.14%	40.84%	-45.80%	97.84%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
research and development	79,233,000	88,937,000	104,380,000	87,164,000	106,946,000	92,679,000	164,697,000	106,229,000	219,475,000	247,101,000	257,850,000	304,297,000	289,648,000	383,483,000	962,957,000	408,195,000	570,685,000	592,671,000	18,611,000	34,846,000	16,895,000	29,340,000	18,611,000	30,417,000	35,473,000	43,415,000	41,326,000	44,542,000	44,514,000	49,656,000	41,862,000	39,263,000	37,654,000	51,100,000	52,983,000	64,904,000	68,952,000	83,958,000	27,917,000	25,042,000	25,888,000	19,219,000	15,202,000	14,518,000	44,069,000	6,239,000	5,584,000	5,414,000	7,870,000	6,327,000	9,029,000	5,256,000	5,297,000	4,266,000	8,655,000	5,380,000	4,434,000	5,634,000	4,193,000	3,659,000	3,193,000	2,903,000	3,401,000	2,032,000	1,316,000	1,161,000	1,377,000	1,222,000	1,541,000	1,552,000	1,229,000	3,047,000	2,345,000	2,554,000	2,792,000
selling, general, and administrative	43,612,000	48,090,000	78,342,000	70,747,000	101,298,000	86,798,000	155,237,000	107,460,000	93,717,000	112,532,000	161,663,000	122,876,000	108,160,000	95,992,000
total expenses	138,170,000	151,142,000	219,391,000	218,530,000	254,486,000	238,686,000	474,910,000	312,618,000	368,969,000	393,719,000	601,278,000	861,766,000	668,885,000	494,679,000	1,047,171,000	485,988,000	643,846,000	655,861,000	17,494,000	52,565,000	26,274,000	37,521,000	17,494,000	40,023,000	44,205,000	52,639,000	49,635,000	52,766,000	53,166,000	58,196,000	49,980,000	48,203,000	46,506,000	59,444,000	66,539,000	79,003,000	79,480,000
income from operations	101,070,000	515,513,000	-131,080,000	-134,018,000	160,998,000	-144,831,000	-183,568,000	-125,632,000	55,457,000	-312,768,000	-243,879,000	-127,189,000	-482,960,000	209,292,000	-824,971,000	-307,144,000	-345,829,000	-208,632,000	-14,987,000	-17,027,000	-22,897,000	-28,705,000	-14,987,000	-36,666,000	-40,223,000	-46,512,000	-41,900,000	-41,993,000	-43,513,000	-47,784,000	-41,628,000	-41,471,000	-40,826,000	-54,045,000	-63,308,000	-76,498,000	-75,262,000	-78,902,000	-33,199,000	-20,821,000	-24,313,000	-19,789,000	-17,851,000	-14,385,000	-992,000	-3,968,000	-5,921,000	-7,430,000	-10,539,000									-9,257,000	-8,725,000	-8,992,000	-6,840,000	-5,694,000	-7,038,000	-5,035,000	6,708,000	-2,237,000	-5,225,000	-8,417,000	-9,908,000	-2,320,000	-7,340,000	-4,896,000	-3,060,000	-2,960,000	-4,632,000	-5,401,000	-4,892,000	-6,339,000	-5,234,000	-5,094,000
yoy	-37.22%	-455.94%	-28.59%	6.68%	190.31%	-53.69%	-24.73%	-1.22%	-111.48%	-249.44%	-70.44%	-58.59%	39.65%	-200.32%	5404.58%	1703.86%	1410.37%	626.81%	0.00%	-53.56%	-43.07%	-38.28%	-64.23%	-12.69%	-7.56%	-2.66%	0.65%	1.26%	6.58%	-11.58%	-34.25%	-45.79%	-45.75%	-31.50%	90.69%	267.41%	209.55%	298.72%	85.98%	44.74%	2350.91%	398.71%	201.49%	93.61%	-90.59%													62.57%	23.97%	78.59%	-201.97%	154.54%	34.70%	-40.18%	-167.70%	-3.58%	-28.81%	71.92%	223.79%	-21.62%	58.46%	-9.35%	-37.45%	-53.30%	-11.50%	6.03%
qoq	-80.39%	-493.28%	-2.19%	-183.24%	-211.16%	-21.10%	46.12%	-326.54%	-117.73%	28.25%	91.75%	-73.66%	-330.76%	-125.37%	168.59%	-11.19%	65.76%	1292.09%	-11.98%	-25.64%	-20.23%	91.53%	-59.13%	-8.84%	-13.52%	11.01%	-0.22%	-3.49%	-8.94%	14.79%	0.38%	1.58%	-24.46%	-14.63%	-17.24%	1.64%	-4.61%	137.66%	59.45%	-14.36%	22.86%	10.86%	24.09%	1350.10%	-75.00%	-32.98%	-20.31%	-29.50%										6.10%	-2.97%	31.46%	20.13%	-19.10%	39.78%	-175.06%	-399.87%	-57.19%	-37.92%	-15.05%	327.07%	-68.39%	49.92%	60.00%	3.38%	-36.10%	-14.24%	10.40%	-22.83%	21.11%	2.75%
operating margin %	42.25%	77.33%	-148.43%	-158.58%	38.75%	-154.31%	-63.01%	-67.19%	13.07%	-386.37%	-68.24%	-17.31%	-259.76%	29.73%	-371.27%	-171.74%	-116.04%	-46.65%	-597.81%	-47.91%	-678.03%	-325.60%	-597.81%	-1092.23%	-1010.12%	-759.13%	-541.69%	-389.80%	-450.77%	-458.93%	-498.42%	-616.03%	-718.77%	-1001.02%	-1959.39%	-3053.81%	-1784.31%	-1348.06%	-508.80%	-148.76%	-246.16%	-240.92%	-216.14%	-192.78%
other income:
interest expense	-5,518,000	-5,723,000	-7,585,000	-4,236,000	-4,143,000	-4,111,000	-4,117,000	-2,859,000	-3,124,000	-4,316,000	-4,601,000	-4,169,000	-6,234,000	-4,876,000	-5,138,000	-5,182,000	-5,968,000	-4,839,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,403,000	-3,523,000	-3,520,000	-3,516,000	-3,513,000	-3,508,000	-3,511,000	-3,512,000	-2,430,000	-115,000	-64,000	-26,000	-36,000	-47,000	-51,000	-52,000	-158,000	-2,000	-2,000	-2,000	-2,000	-2,000	-2,000							-458,000		604,000	-348,000	-341,000		-460,000	-553,000	-490,000	-491,000	-469,000	-451,000	-337,000	-377,000	-362,000	-23,000	-401,000	-396,000	-401,000	221,500	375,000	263,000	-248,000
other income	11,902,000	10,056,000	13,135,000	15,922,000	7,731,000	3,654,000	10,984,000	-2,982,000	5,532,000	24,362,000	63,971,000	-34,783,000	-19,873,000	1,654,000	131,000	-4,394,000	2,659,000	-6,593,000	5,000	2,612,000		2,000	5,000	-8,000	-12,000	-3,000	-19,000	97,000	33,000	47,000	10,000	-1,000	11,000	2,000	11,000	-11,000	-33,000	1,000	-51,000	72,000	-142,000	-19,000	18,000						136,000			732,000	-710,000	-1,212,000
income before income tax expense	107,454,000	519,846,000								-292,722,000	-184,509,000	-166,141,000	-509,067,000	206,070,000
income tax expense	946,000	1,200,000				2,262,000				1,183,000	-2,260,000	2,472,000	1,418,000	2,662,000	16,609,000	6,041,000	3,548,000	3,017,000																													412,000
net income	106,508,000	518,646,000	-81,030,000	-121,300,000	162,381,000	-147,550,000	-178,389,000	-130,776,000	58,008,000	-293,905,000	-182,249,000	-168,613,000	-510,485,000	203,408,000	-846,284,000	-322,431,000	-352,317,000	-222,719,000	-18,043,000	-17,521,000	-25,864,000	-31,830,000	-18,043,000	-39,603,000	-43,218,000	-49,334,000	-44,570,000	-44,492,000	-46,352,000	-50,842,000	-44,607,000	-44,465,000	-43,854,000	-57,109,000	-66,254,000	-79,351,000	-77,252,000	-78,806,000	-33,120,000	-20,641,000	-24,370,000	-19,727,000	-17,864,000	-13,810,000	-48,771,000	-3,212,000	-4,993,000	-7,453,000	-10,355,000	-9,426,000	-11,412,000	-7,530,000	-8,540,000	-8,349,000	-7,842,000	-9,372,000	-7,755,000	-8,966,000	-8,194,000	-8,388,000	-6,148,000	-5,014,000	-6,411,000	-5,495,000	6,155,000	-2,727,000	-5,716,000	-8,886,000	-10,289,000	-2,657,000	-7,717,000	-5,258,000	-3,083,000	-3,361,000	-5,028,000	-5,802,000	-5,145,000	-6,714,000	-5,497,000	-5,342,000
yoy	-34.41%	-451.51%	-54.58%	-7.25%	179.93%	-49.80%	-2.12%	-22.44%	-111.36%	-244.49%	-78.46%	-47.71%	44.89%	-191.33%	4590.37%	1740.25%	1262.19%	599.71%	0.00%	-55.76%	-40.15%	-35.48%	-59.52%	-10.99%	-6.76%	-2.97%	-0.08%	0.06%	5.70%	-10.97%	-32.67%	-43.96%	-43.23%	-27.53%	100.04%	284.43%	217.00%	299.48%	85.40%	49.46%	-50.03%	514.17%	257.78%	85.29%	370.99%	-65.92%	-56.25%	-1.02%	21.25%	12.90%	45.52%	-19.65%	10.12%	-6.88%	-4.30%	11.73%	26.14%	78.82%	27.81%	52.65%	-199.89%	83.87%	12.16%	-38.16%	-159.82%	2.63%	-25.93%	69.00%	233.73%	-20.95%	53.48%	-9.38%	-40.08%	-49.94%	-8.53%	8.61%
qoq	-79.46%	-740.07%	-33.20%	-174.70%	-210.05%	-17.29%	36.41%	-325.44%	-119.74%	61.27%	8.09%	-66.97%	-350.97%	-124.04%	162.47%	-8.48%	58.19%	1134.38%	2.98%	-32.26%	-18.74%	76.41%	-54.44%	-8.36%	-12.40%	10.69%	0.18%	-4.01%	-8.83%	13.98%	0.32%	1.39%	-23.21%	-13.80%	-16.51%	2.72%	-1.97%	137.94%	60.46%	-15.30%	23.54%	10.43%	29.36%	-71.68%	1418.40%	-35.67%	-33.01%	-28.03%	9.86%	-17.40%	51.55%	-11.83%	2.29%	6.47%	-16.33%	20.85%	-13.51%	9.42%	-2.31%	36.43%	22.62%	-21.79%	16.67%	-189.28%	-325.71%	-52.29%	-35.67%	-13.64%	287.24%	-65.57%	46.77%	70.55%	-8.27%	-33.15%	-13.34%	12.77%	-23.37%	22.14%	2.90%
net income margin %	44.52%	77.80%	-91.76%	-143.53%	39.08%	-157.21%	-61.23%	-69.94%	13.67%	-363.07%	-50.99%	-22.95%	-274.57%	28.89%	-380.87%	-180.29%	-118.22%	-49.80%	-719.70%	-49.30%	-765.89%	-361.05%	-719.70%	-1179.71%	-1085.33%	-805.19%	-576.21%	-413.00%	-480.18%	-488.30%	-534.09%	-660.50%	-772.08%	-1057.77%	-2050.57%	-3167.70%	-1831.48%	-1346.42%	-507.59%	-147.48%	-246.73%	-240.16%	-216.30%	-185.07%
net income per share																																																				-0.08	-0.1	-0.12	-0.12	-0.15	-0.13
basic	0.66	3.22			1.09				0.65	-3.41			-6.53	2.66
diluted	0.62	2.93			0.99				0.58	-3.41				2.56
weighted-average number of common shares outstanding:
basic	162,019	161,049			148,379				89,362	86,158			78,143	76,457
diluted	177,215	177,625			165,855				104,065	86,158				80,711
grants							37,943,000	164,922,000	137,079,000	87,379,000	69,573,000	106,273,000	107,774,000	99,301,000
income before income tax benefit			-25,758,500	-122,332,000	164,586,000				57,865,000
income tax benefit			858,750	-1,032,000	2,205,000		85,750	-697,000	-143,000
net income per share																																																				-0.08	-0.1	-0.12	-0.12	-0.15	-0.13
basic and diluted			-0.52	-0.76		-1.05	-1.47	-1.26			-2.29	-2.15
weighted-average number of common shares outstanding:
basic and diluted			152,190	160,049		139,916	100,768	103,429			78,183	78,274
royalties and other						11,531,000	1,947,000	19,833,000	2,184,000	1,029,000	39,000	2,213,000	22,696,000	19,042,000
income before income taxes						-145,288,000	-91,582,500	-131,473,000
weighted-average number of common shares outstanding
basic and diluted			152,190	160,049		139,916	100,768	103,429			78,183	78,274
weighted-average number of common shares outstanding
basic	162,019	161,049			148,379				89,362	86,158			78,143	76,457
diluted	177,215	177,625			165,855				104,065	86,158				80,711
net income per share																																																				-0.08	-0.1	-0.12	-0.12	-0.15	-0.13
basic	0.66	3.22			1.09				0.65	-3.41			-6.53	2.66
weighted-average number of common shares outstanding
basic	162,019	161,049			148,379				89,362	86,158			78,143	76,457
government contracts															180,185,000	97,502,000	240,534,000	382,704,000																2,000	102,000	134,000	1,946,000	4,071,000	6,307,000	13,720,000	9,246,000	7,504,000	7,241,000	5,472,000
grant and other															34,988,000	41,401,000	34,026,000	64,525,000	2,507,000	35,538,000	3,377,000	1,316,000	2,507,000	3,357,000	3,982,000	6,127,000	7,735,000	10,773,000	9,653,000
royalties															15,849,500	39,941,000	23,457,000
general and administrative															84,214,000	77,793,000	73,161,000	63,190,000	7,899,000	17,719,000	9,379,000	8,181,000	7,899,000	9,606,000	8,732,000	9,224,000	8,309,000	8,224,000	8,652,000	8,540,000	8,118,000	8,940,000	8,852,000	8,344,000	13,556,000	14,099,000	10,528,000	8,851,000	9,060,000	7,088,000	5,843,000	4,757,000	5,806,000	4,308,000	12,082,000	2,737,000	3,338,000	2,850,000	2,844,000	3,148,000	2,535,000	3,207,000	2,562,000		1,265,000	3,166,000	3,244,000	3,085,000			3,327,000	2,530,000	2,610,000	2,720,000	2,005,000	1,694,000	2,292,000	2,121,000	2,724,000	1,901,000	2,059,000	2,032,000	2,373,000	1,911,000	1,810,000
investment income															303,000	330,000	369,000	362,000	342,000	297,000	436,000	276,000	342,000	474,000	420,000	584,000	752,000	807,000	531,000	418,000	531,000	523,000	474,000	442,000	554,000	670,000	473,000	210,000	194,000	134,000	121,000
net income before income tax expense															-221,215,250	-316,390,000	-348,769,000	-219,702,000
basic and diluted net income per share															-11.31	-4.31	-4.75	-3.05	-0.74	-0.3	-0.58	-1.08	-0.74	-1.69	-0.11	-0.13	-0.12	-0.12	-0.14	-0.16	-0.15	-0.16	-0.16	-0.21	-0.24	-0.29	-0.29	-0.3	-0.12	-0.08	-0.1	-0.08	-0.08	-0.07	-0.008	-0.03	-0.04	-0.07	-0.1	-0.09	-0.11										-0.073	-0.08											-0.123	-0.11			-0.18	-0.27	-0.22	-0.22
basic and diluted weighted-average number of common shares outstanding															74,400	74,745	74,118	73,035	24,327	58,618	44,421	24,100	24,327	23,473	408,843	369,757	382,315	375,923	336,972	292,669	296,435	283,444	274,178	270,802	271,064	270,760	270,179	262,248	269,554	268,083	241,223	238,304	217,178		169,658	115,107	112,821	111,188	107,092	100,694	100,188	92,297,263	84,832,226	68,692,455	66,521,776	61,329,699	61,280,155	61,399,445	61,311,954	61,221,075			61,465,003	52,267,386	42,758,302	43,469,637	39,553,876	39,553,876	36,926,034	38,577,458	34,779,657	34,722,402	29,852,797		29,988,875	26,990,427	24,433,868

government contract
gain on catalent transaction																			-9,016,000				-9,016,000
research and development collaborations																														5,191,000	8,352,000	6,732,000	5,680,000	5,397,000	3,129,000	2,371,000	2,272,000	1,782,000	218,000	276,000	631,000	710,000	1,018,000	1,990,000
costs and expenses:
cost of government contracts revenue																																						2,013,500	2,747,000	2,687,000	2,459,000	4,027,000	5,102,000	3,021,000
total costs and expenses																																						27,182,750	39,724,000	34,817,000	34,190,000	28,003,000	26,110,000	21,847,000
realized gains on marketable securities
interest income																																										128,000	20,000	12,000	165,000	22,000	38,000	46,000	50,000	44,000	44,000				-604,000	-110,000	117,000	749,000	531,000		-700,000	1,021,000
change in fair value of warrant liability																																													-469,000	736,000	1,304,000	-67,000
realized gains on investments																																												615,000
income from operations before income tax																																										-19,727,000	-17,864,000	-13,810,000	-803,000	-3,212,000	-4,581,000
basic and diluted weighted-average number of common shares outstanding																																												208,927
revenue																																													1,252,000	5,008,000	3,001,000	834,000	175,000	7,000	110,000
operating expenses:
total operating expenses																																													2,244,000	8,976,000	8,922,000	8,264,000	10,714,000	9,475,000	11,564,000
income tax (benefit) expense
impairment of short-term investments
realized gains on short-term investments
income from continuing operations																																																		-9,468,000	-11,454,000	-7,530,000	-8,540,000	-8,349,000	-10,330,000	-8,314,000	-7,103,000
revenues																																																				201,000	29,000	21,000
operating costs and expenses:
total operating costs and expenses																																																				8,463,000	7,859,000	7,158,000	9,920,000	8,546,000	7,678,000	10,572,000	8,883,000	9,660,000	8,188,000	6,887,000	7,877,000	6,338,000	-4,464,000	4,104,000	7,540,000	9,379,000	11,954,000	2,309,000	10,345,000	8,116,000
income from operations before other income																																																				-8,262,000	-7,830,000
income from discontinued operations																																																							2,488,000	-1,058,000	-652,000
basic and diluted net income per share:
loss per share from continuing operations																																																				-0.08	-0.1	-0.12	-0.16		-0.12
income per share from discontinued operations
net income per share																																																				-0.08	-0.1	-0.12	-0.12	-0.15	-0.13
loss per share from discontinued operations																																																								-0.02	-0.01
selling, general and administrative																																																						2,892,000					3,362,000	4,597,000
income from continuing operations before other income																																																						-7,137,000
revenues:
net product sales																																																										453,000	-64,000	357,000	833,000	571,000	378,000	719,000	641,000	1,300,000	1,889,000	719,000	2,207,000	-664,000	2,656,000	2,197,000
contract research and development																																																							142,000	325,000	458,000	710,000	110,000	222,000	427,000	582,000	403,000	474,000	712,000	417,000	426,000	243,000	-161,000	653,000	286,000	960,000	284,000	560,000	253,000
royalties, milestone and licensing fees																																																							52,000	17,000				89,000	88,000	40,000	58,000	110,000
total revenues																																																							194,000	342,000	458,000	1,315,000	158,000	668,000	1,348,000	1,193,000	839,000	1,303,000	2,244,000	1,867,000	2,315,000	962,000	2,046,000	-11,000	3,005,000	3,220,000
cost of products sold																																																										1,096,000	855,000	1,317,000	1,360,000	1,170,000	1,161,000	1,233,000	717,000	1,068,000	2,027,000	1,979,000	1,362,000	364,000	1,501,000	263,000
income from continuing operations before interest income																																																							-9,726,000	-8,204,000	-7,220,000
gain per share from discontinued operations																																																							0.04
basic and diluted net income per share: loss per share from continuing operations																																																								-0.14
basic and diluted loss per share:
royalties and milestone fees																																																										152,000
excess inventory costs over market																																																										757,000	473,000	87,000	293,000	264,000	677,000	315,000
basic and diluted loss per share																																																										-0.15	-0.13	-0.14			-0.1	-0.11	0.16	-0.06	-0.14	-0.22	-0.27	-0.07	-0.22	-0.15			-0.17	-0.22
royalities, milestone and licensing fees																																																											112,000
selling and marketing																																																													15,000	20,000	28,000	38,000	88,000	930,000	1,844,000	4,057,000	6,327,000	8,931,000	5,556,000	2,774,000
facility exit costs																																																																		107,000				723,000
gain on sale of product assets																																																																	-214,000	-856,000
total other income																																																													211,750	680,000
weighted-average number of common shares used in computing basic and diluted net income per share																																																													58,664,365	61,500,942
interest income / (expense)																																																															627,000
milestone and licensing fees																																																																	37,500	150,000					63,000	63,000	63,000	62,000	63,000					813,000
gain on redemption of debt																																																																						-11,162,000
basic and diluted weighted-average number of common outstanding																																																																										30,134,586
operating costs and expense:
weighted-average shares used for eps calculation																																																																														24,653,759	24,563,612	23,851,186
contract research & development																																																																																505,000

We provide you with 20 years income statements for Novavax stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Novavax stock. Explore the full financial landscape of Novavax stock with our expertly curated income statements.

The information provided in this report about Novavax stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.